과제정보
This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government [Ministry of Science, Information and Communication Technology and Future Planning (MSIP)] (2016R1A5A2945889 and 2020R1A2C2003268).
참고문헌
- Yoo JY, Wang XW, Rishi AK et al (2000) Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Brit J Cancer 82, 683-690 https://doi.org/10.1054/bjoc.1999.0981
- Liu Z, Ahn JY, Liu X and Ye K (2006) Ebp1 isoforms distinctively regulate cell survival and differentiation. Proc Natl Acad Sci U S A 103, 10917-10922 https://doi.org/10.1073/pnas.0602923103
- Ahn JY, Liu X, Liu Z et al (2006) Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J 25, 2083-2095 https://doi.org/10.1038/sj.emboj.7601111
- Kim CK, Nguyen TLX, Joo KM et al (2010) Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. Cancer Res 70, 9730-9741 https://doi.org/10.1158/0008-5472.CAN-10-1882
- Ko HR, Kim CK, Lee SB et al (2014) P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP. Cell Death Dis 5, e1131-e1131 https://doi.org/10.1038/cddis.2014.79
- Hwang I and Ahn JY (2020) Dysregulation of epigenetic control contributes to Schizophrenia-like behavior in Ebp1+/- mice. Int J Mol Sci 21, 2609 https://doi.org/10.3390/ijms21072609
- Ko HR, Hwang I, Ahn SY, Chang YS, Park WS, and Ahn JY (2017) Neuron-specific expression of p48 Ebp1 during murine brain development and its contribution to CNS axon regeneration. BMB Rep 50, 126-131 https://doi.org/10.5483/BMBRep.2017.50.3.190
- Ko HR, Hwang I, Jin EJ et al (2019) Roles of ErbB3-binding protein 1 (EBP1) in embryonic development and gene-silencing control. Proc Natl Acad Sci U S A 116, 24852-24860 https://doi.org/10.1073/pnas.1916306116
- Kim CK, Lee SB, Nguyen TLX et al (2012) Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization. Exp Cell Res 318, 136-143 https://doi.org/10.1016/j.yexcr.2011.08.013
- Boros J, Arnoult N, Stroobant V, Collet JF and Decottignies A (2014) Polycomb repressive complex 2 and H3K27me3 cooperate with H3K9 methylation to maintain heterochromatin protein 1α at chromatin. Mol Cell Biol 34, 3662-3674 https://doi.org/10.1128/MCB.00205-14
- Towbin BD, Gonzalez-Aguilera C, Sack R et al (2012) Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 150, 934-947 https://doi.org/10.1016/j.cell.2012.06.051
- Bosch-Presegue L, Raurell-Vila H, Marazuela-Duque A et al (2011) Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection. Mol Cell 42, 210-223 https://doi.org/10.1016/j.molcel.2011.02.034
- Marine JC and Lozano G (2010) Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 17, 93-102 https://doi.org/10.1038/cdd.2009.68
- Chen L, Li Z, Zwolinska AK et al (2010) MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output. EMBO J 29, 2538-2552 https://doi.org/10.1038/emboj.2010.140
- Dambacher S, Hahn M and Schotta G (2010) Epigenetic regulation of development by histone lysine methylation. Heredity 105, 24-37 https://doi.org/10.1038/hdy.2010.49
- Peters AHFM, O'Carroll D, Scherthan H et al (2001) Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-337 https://doi.org/10.1016/S0092-8674(01)00542-6
- Nguyen LXT, Zhu L, Lee Y, Ta L and Mitchell BS (2016) Expression and role of the ErbB3-binding protein 1 in acute myelogenous leukemic cells. Clin Cancer Res 22, 3320-3327 https://doi.org/10.1158/1078-0432.CCR-15-2282
- Ko HR, Chang YS, Park WS and Ahn JY (2016) Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells. Int J Cancer 139, 1202-1208 https://doi.org/10.1002/ijc.30165
- Nguyen CT, Weisenberger DJ, Velicescu M et al (2002) Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res 62, 6456-6461